z-logo
open-access-imgOpen Access
Clinical predictors of community-genotype ST72-methicillin-resistant Staphylococcus aureus-SCCmec type IV in patients with community-onset S. aureus infection
Author(s) -
EunJeong Joo,
Doo Ryeon Chung,
Young Eun Ha,
S. Y. Park,
H. A. Kim,
Min-Jung Lim,
Hong Bin Kim,
CheolIn Kang,
Nam Yong Lee,
Kwan Soo Ko,
Kyong Ran Peck,
JaeUk Song
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks120
Subject(s) - staphylococcus aureus , sccmec , genotype , methicillin resistant staphylococcus aureus , microbiology and biotechnology , staphylococcal infections , panton–valentine leukocidin , micrococcaceae , meticillin , medicine , virology , biology , antibacterial agent , antibiotics , gene , bacteria , genetics
Community-genotype methicillin-resistant Staphylococcus aureus (MRSA) clones have emerged in the community worldwide and recently have been spreading into the hospitals. To identify predictors of sequence type 72-MRSA-SCCmec type IV (ST72-MRSA-IV) in patients with community-onset (CO) S. aureus infection, a case-control study was conducted among CO S. aureus infections, including healthcare-associated infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom